Earnings PreviewAKTX
AKTX Crashes 41% — Earnings Tomorrow Will Test the Thesis
Akari Therapeutics heads into tomorrow's earnings report having shed nearly half its value in a week, making the print less a routine update and more a reckoning. The price collapse is the dominant fact here. The stock…
1 min read
